Effects of perfluorooctanoic acid on mouse mammary gland development and differentiation resulting from cross-foster and restricted gestational exposures

Reproductive Toxicology

Volumn 27, Issue 3-4, 2009, Pages 289-298

  White, Sally S ^a,b   Kato, Kayoko ^c   Jia, Lily T ^c   Basden, Brian J ^c   Calafat, Antonia M ^c   Hines, Erin P ^a   Stanko, Jason P ^a   Wolf, Cynthia J ^a   Abbott, Barbara D ^a   Fenton, Suzanne E ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

Delayed development; Dosimetry; Fetal origins of adult disease; Lactation; Mammary gland; Neonatal exposure; Perfluorooctanoic acid (PFOA); Prenatal exposure

Indexed keywords

PERFLUOROOCTANOIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST DEVELOPMENT; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; FEMALE; FETUS; LACTATION; MAMMARY GLAND; MOUSE; NONHUMAN; PREGNANCY; PRENATAL EXPOSURE; TISSUE DIFFERENTIATION;

ANIMALS; ENVIRONMENTAL POLLUTANTS; FEMALE; FETAL DEVELOPMENT; FLUOROCARBONS; GESTATIONAL AGE; MAMMARY GLANDS, ANIMAL; MATERNAL DEPRIVATION; MATERNAL EXPOSURE; MICE; MICE, INBRED STRAINS; OCTANOIC ACIDS; PREGNANCY; RANDOM ALLOCATION;

MUS;

EID: 67349156635     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2008.11.054     Document Type: Article

References (35)

1. Giesy J.P., and Kannan K. Perfluorochemical surfactants in the environment. Environ Sci Technol 36 (2002) 146A-152A
2. Hansen K.J., Johnson H.O., Eldridge J.S., Butenhoff J.L., and Dick L.A. Quantitative characterization of trace levels of PFOS and PFOA in the Tennessee River. Environ Sci Technol 36 (2002) 1681-1685
3. Harada K., Saito N., Inoue K., Yoshinaga T., Watanabe T., Sasaki S., et al. The influence of time, sex and geographic factors on levels of perfluorooctane sulfonate and perfluorooctanoate in human serum over the last 25 years. J Occup Health 46 (2004) 141-147
4. Hoff P.T., Van de Vijver K., Van Dongen W., Esmans E.L., Blust R., and De Coen W.M. Perfluorooctane sulfonic acid in bib (Trisopterus luscus) and plaice (Pleuronectes platessa) from the Western Scheldt and the Belgian North Sea: distribution and biochemical effects. Environ Toxicol Chem 22 (2003) 608-614
5. Kannan K., Corsolini S., Falandysz J., Oehme G., Focardi S., and Giesy J.P. Perfluorooctanesulfonate and related fluorinated hydrocarbons in marine mammals, fishes, and birds from coasts of the Baltic and the Mediterranean Seas. Environ Sci Technol 36 (2002) 3210-3216
6. Key B.D., Howell R.D., and Criddle C.S. Fluorinated organics in the biosphere. Environ Sci Technol 31 (1997) 2445-2454
7. Kubwabo C., Vais N., and Benoit F.M. A pilot study on the determination of perfluorooctanesulfonate and other perfluorinated compounds in blood of Canadians. J Environ Monit 6 (2004) 540-545
8. Olsen G.W., Burris J.M., Burlew M.M., and Mandel J.H. Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. J Occup Environ Med 45 (2003) 260-270
9. Olsen G.W., Church T.R., Miller J.P., Burris J.M., Hansen K.J., Lundberg J.K., et al. Perfluorooctanesulfonate and other fluorochemicals in the serum of American Red Cross adult blood donors. Environ Health Perspect 111 (2003) 1892-1901
10. Calafat A.M., Wong L.Y., Kuklenyik Z., Reidy J.A., and Needham L.L. Polyfluoroalkyl chemicals in the U.S. population: data from the National Health and Nutrition Examination Survey (NHANES) 2003-2004 and comparisons with NHANES 1999-2000. Environ Health Perspect 115 (2007) 1596-1602
11. Wolf C.J., Fenton S.E., Schmid J.E., Calafat A.M., Kuklenyik Z., Bryant X.A., et al. Developmental toxicity of perfluorooctanoic acid in the CD-1 mouse after cross-foster and restricted gestational exposures. Toxicol Sci 95 (2007) 462-473
12. Emmett E.A., Shofer F.S., Zhang H., Freeman D., Desai C., and Shaw L.M. Community exposure to perfluorooctanoate: relationships between serum concentrations and exposure sources. J Occup Environ Med 48 (2006) 759-770
13. Kennedy Jr. G.L., Butenhoff J.L., Olsen G.W., O'Connor J.C., Seacat A.M., Perkins R.G., et al. The toxicology of perfluorooctanoate. Crit Rev Toxicol 34 (2004) 351-384
14. U.S. Environmental Protection Agency [EPA], Office of Pollution Prevention and Toxics, and Risk Assessment Division. SAB review of EPA's draft risk assessment of the potential human health effects associated with exposure to perflurooctanoic acid and its salts (EPA-SAB-06-006) (2006), Science Advisory Board Perfluorooctanoic Acid Review Panel, Washington, DC
15. Lau C., Thibodeaux J.R., Hanson R.G., Narotsky M.G., Rogers J.M., Lindstrom A.B., et al. Effects of perfluorooctanoic acid exposure during pregnancy in the mouse. Toxicol Sci 90 (2006) 510-518
16. Abbott B.D., Wolf C.J., Schmid J.E., Das K.P., Zehr R.D., Helfant L., et al. Perfluo rooctanoic acid induced developmental toxicity in the mouse is dependent on expression of peroxisome proliferator activated receptor-alpha. Toxicol Sci 98 (2007) 571-581
17. White S.S., Calafat A.M., Kuklenyik Z., Villanueva L., Zehr R.D., Helfant L., et al. Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring. Toxicol Sci 96 (2007) 133-144
18. Apelberg B.J., Witter F.R., Herbstman J.B., Calafat A.M., Halden R.U., Needham L.L., et al. Cord serum concentrations of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in relation to weight and size at birth. Environ Health Perspect 115 (2007) 1670-1676
19. Fei C., McLaughlin J.K., Tarone R.E., and Olsen J. Perfluorinated chemicals and fetal growth: a study within the Danish National Birth Cohort. Environ Health Perspect 115 (2007) 1677-1682
20. Fei C., McLaughlin J.K., Tarone R.E., and Olsen J. Fetal growth indicators and perfluorinated chemicals: a study in the Danish National Birth Cohort. Am J Epidemiol 168 (2008) 66-72
21. Kärrman A., Ericson I., van Bavel B., Darnerud P.O., Aune M., Glynn A., et al. Exposure of perfluorinated chemicals through lactation: levels of matched human milk and serum and a temporal trend, 1996-2004, in Sweden. Environ Health Perspect 115 (2007) 226-230
22. Monroy R., Morrison K., Teo K., Atkinson S., Kubwabo C., Stewart B., et al. Serum levels of perfluoroalkyl compounds in human maternal and umbilical cord blood samples. Environ Res 108 (2008) 56-62
23. Tao L., Kannan K., Wong C.M., Arcaro K.F., and Butenhoff J.L. Perfluorinated compounds in human milk from Massachusetts, U.S.A. Environ Sci Technol 42 (2008) 3096-3101
24. Völkel W., Genzel-Boroviczény O., Demmelmair H., Gebauer C., Koletzko B., Twardella D., et al. Perfluorooctane sulphonate (PFOS) and perfluorooctanoic acid (PFOA) in human breast milk: results of a pilot study. Int J Hyg Environ Health 211 (2008) 440-446
25. Fenton S.E., Hamm J.T., Birnbaum L.S., and Youngblood G.L. Persistent abnormalities in the rat mammary gland following gestational and lactational exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Sci 67 (2002) 63-74
26. Rayner J.L., Wood C., and Fenton S.E. Exposure parameters necessary for delayed puberty and mammary gland development in Long-Evans rats exposed in utero to atrazine. Toxicol Appl Pharmacol 195 (2004) 23-34
27. Kuklenyik Z., Needham L.L., and Calafat A.M. Measurement of 18 perfluorinated organic acids and amides in human serum using on-line solid-phase extraction. Anal Chem 77 (2005) 6085-6091
28. Lau C., Strynar M.J., Lindstrom A.B., Hanson R.G., Thibodeaux J.R., and Barton H.A. Pharmacokinetic evaluation of perfluorooctanoic acid in the mouse. Toxicologist 84 (2005) 252
29. Hinderliter P.M., Mylchreest E., Gannon S.A., Butenhoff J.L., and Kennedy Jr. G.L. Perfluorooctanoate: placental and lactational transport pharmacokinetics in rats. Toxicology 211 (2005) 139-148
30. Daniel C.W., and Silberstein G.B. Postnatal development of the rodent mammary gland. In: Neville M.C., and Daniel C.W. (Eds). The mammary gland: development, regulation, and function (1987), Plenum Press, New York 3-36
31. Fenton S.E. Endocrine-disrupting compounds and mammary gland development: early exposure and later life consequences. Endocrinology 147 (2006) S18-24
32. Yang C., Tan Y.S., Harkema J.R., and Haslam S.Z. Differential effects of peripubertal exposure to perfluorooctanoic acid on mammary gland development in C57Bl/6 and Balb/c mouse strains. Reprod Toxicol 27 (2009) 299-306
33. Yang Q., Kurotani R., Yamada A., Kimura S., and Gonzalez F.J. PPARα activation during pregnancy severely impairs mammary lobuloalveolar development in mice. Endocrinology 147 (2006) 4772-4780
34. Breast Cancer and Environment Research Centers; 2008. Available at: http://www.bcerc.org [Accessed August 8, 2008].
35. C8 Science Panel; 2008. Available at: http://www.c8sciencepanel.org [Accessed August 8, 2008].